About this trial
This study aims to analyze whether there is a significant difference in the occurrence of postpartum hemorrhage between women who underwent umbilical cord drainage and those who did not. Variables such as estimated blood loss volume, drop in hemoglobin levels, and the need for additional maneuvers or treatments to control hemorrhage will be examined. The research will be conducted under a parallel-group clinical trial design at the Hospital Escuela Universitario. Post-birth umbilical cord drainage may contribute to a lower frequency of postpartum hemorrhage compared to not performing it.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Pregnant women aged 18-49 years.
Singleton pregnancy.
Gestational age ≥37 weeks.
active labor with cephalic presentation.
Disqualifiers
Planned or emergent cesarean section.
Instrumental delivery (e.g., forceps, vacuum).
Antepartum hemorrhage.
Severe anemia (Hemoglobin <8 g/dL) or specific hematological disorders (e.g., sickle cell disease, thalassemia, hemophilia, thrombocytopenia <100,000/µL).
Trial design
Parallel
Treatments tested in this trial
Umbilical Cord Drainage
Procedure/SurgeryFollowing delivery of the newborn and immediate clamping/cutting of the umbilical cord, the maternal end of the cord is unclamped and allowed to drain passively. The cord is held over a sterile, graduated collection drape (Brass-V Drape) to facilitate the complete, gravity-dependent emptying of the residual placental blood (approximately 50-100 mL) prior to placental delivery. The procedure is completed within 1-3 minutes, after which standard controlled cord traction is applied to assist placental expulsion. This is a non-invasive adjunct to active management of the third stage of labor.
Standard Active Management of Third Stage (No Cord Drainage)
Other interventionThis arm receives the standard, evidence-based active management of the third stage of labor, as per institutional protocol, without the specific addition of umbilical cord drainage. The procedure includes immediate administration of a prophylactic uterotonic agent (e.g., oxytocin), delayed cord clamping (as per routine practice), controlled cord traction with counter-pressure on the uterus (Brandt-Andrews maneuver) to assist placental delivery, and uterine massage after placental expulsion. All blood loss is collected and measured in a standard graduated drape. This represents the current standard of care against which the experimental intervention is compared.
Treatment groups
Trial outcomes
Primary outcomes
Change in Postpartum Blood Loss Volume
Difference between estimated blood loss volume in the first 24 hours postpartum and an immediate postpartum baseline. Measured using a calibrated drape (Brass-V Drape)
Secondary outcomes
Change in Hemoglobin Levels
Difference between pre-delivery and postpartum (6-24 hours) hemoglobin levels (g/dL).
Need for Additional Therapeutic Interventions
Requirement for additional uterotonics, uterine revision, blood transfusion, or surgical procedures to control hemorrhage.
Incidence of Cord Management-Related Adverse Events
Occurrence of events such as retained placenta, hypovolemic shock.
Maternal Satisfaction Score
Maternal satisfaction with the intrapartum experience is measured using the validated Birth Satisfaction Scale-Revised (BSS-R). This is a 10-item self-report questionnaire with three subscales: Quality of Care, Women's Personal Attributes, and Stress Experienced During Labor. Items are scored on a 4-point Likert scale (0-3). The total score ranges from 0 to 30, with a higher total score indicating greater birth satisfaction.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.